Clinical Trial Update: Topical Aminolevulinic Acid in Patients With Nonmelanoma Skin Cancer [EARLY_Phase 1]

View source ↗

Summary

A Phase 1 study evaluating topical 5-aminolevulinic acid for non-melanoma skin cancer has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-melanoma Skin Cancer

Drugs mentioned

• Levulan (aminolevulinic acid)

Snippet

Sponsor: The Cleveland Clinic | Conditions: Non-melanomatous Skin Cancer | EARLY_Phase 1 | Status: TERMINATED